Current Status of Blood Purification in Critical Care in JapanKaizu K. · Inada Y. · Kawamura A. · Oda S. · Hirasawa H.
Survey Committee, Japan Society for Blood Purification in Critical Care, Yokohama, Japan
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
In order to clarify the present status of blood purification therapy (BPT) in critical care in Japan, questionnaires investigating all the patients who were treated with BPT in 2005 were distributed. The number of patients who received BPT was 9,795, and the number of BPT performed was 11,623. The number and types of BPT treatment given are: continuous hemodiafiltration (CHDF)/hemofiltration (HDF) 5,443 (50.3%); continuous hemofiltration (CHF) 812 (7.5%); continuous hemodialysis (CHD) 877 (8.1%); simple plasma exchange 898 (8.3%); direct hemoperfusion (DHP) with polymyxin-B-coated textile (PMX-DHP) 1,625 (15.0%); DHP with activated carbon (AC-DHP) 129 (1.2%). The survival rates of patients with continuous therapies (CHDF, CHF, CHD) were as follows: multiple organ failure with CHDF 35%; sepsis with CHDF 65%; acute hepatic failure with CHDF 50%; acute renal failure with CHDF 66%; acute drug intoxication with AC-DHP 79%. In conclusion, continuous therapies such as CHDF, CHF and CHD were the most popular modes ( > 65%) of BPT in Japan. The worst survival rate among diseases in critical care was found in multiple organ failure patients. The best survival rate was in those who suffered from acute renal failure.
© 2010 S. Karger AG, Basel
Burchardi H: History and development of continuous renal replacement techniques. Kid Int Suppl 1998;53:(suppl 66)s12-s124
Bellomo R, Ronco C: Continuous versus intermittent renal replacement therapy in the intensive care unit. Kid Int Suppl 1998;53:(suppl 66)s125-s128
Bellomo R, Tipping P, Boyce N: Continuous veno venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993;21:522-526
Grootendost AF, van Bommel FH, van del Hoven B, van Leengoed LA, van Osia AL: High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992;18:235-240
Bellomo R, Ronco C: Continuous hemofiltration in the intensive care unit. Critical Care 2000;14:339-345
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.